Incyte Corp (INCY)
Industry Biotechnology
This stock can be held in an Investment ISA and an Investment Account
Sell
$60.60
Buy
$70.00
$-0.98 (-1.48%)
Incyte Corp is a biopharmaceutical company. It discovers, develops and commercializes proprietary therapeutics. Its product JAKAFI, a JAK1 and JAK2 inhibitor is used for treatment of patients with intermediate or high risk myelofibrosis.
Prices updated at 30 May 2025, 22:55 EDT
| Prices minimum 15 mins delay
|
Prices in USD
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
Share price chart
Please note that past performance is not a reliable indicator of future returns.